摘要
目的 观察全胸腔镜手术对早期肺癌的临床治疗效果.方法 选取2020年3月～2022年3月本院收治的40例早期肺癌患者为本次研究对象,按照是否开展全胸腔镜手术将患者分为对照组(20例:传统开胸手术)与实验组(20例:全胸腔镜手术),比较两组患者治疗效果.结果 实验组患者术后24 h生理应激指标[皮质醇为(525.64±38.64)nmol/L、(112.43±15.64)ng/L、白细胞介素-6为(82.43±10.58)ng/L、C反应蛋白为(88.98±10.54)mg/L、]、肿瘤因子指标[CA125为(80.53±16.76)kU/L、CEA为(7.23±0.32)μg/L、NSE为(16.76±1.32)U/mL、CA19-9为(68.53±2.54)kU/L]、临床指标、术后并发症发生率(20.00％),均优于对照组,差异有统计学意义(P ＜ 0.05).结论 早期肺癌患者全胸腔镜手术治疗效果显著优于传统开胸手术.
Abstract
Objective To observe the clinical effect of thoracoscopic surgery on early lung cancer. Methods A total of 40 patients with early lung cancer admitted to our hospital from March 2020 to March 2022 were selected as subjects of this study. The patients were divided into control group (20 cases: traditional thoracoscopic surgery) and experimental group (20 cases: thoracoscopic surgery) according to whether they had undergone thoracoscopic surgery, and the therapeutic effects of the two groups were compared. Results Experimental group 24 h physiological stress index [cortisol was (525.64±38.64) nmol/L, (112.43±15.64) ng/L, interleukin-6 was (82.43±10.58) ng/L, C-reactive protein was (88.98±10.54) mg/L,] , tumor factor index [CA125 was (80) 53±16.76) kU/L, CEA was (7.23±0.32) μg/L, NSE was (16.76±1.32) U/mL, CA19-9 was (68.53±2.54) kU/L] , clinical indexes and postoperative complication rate (20.00％) were better than the control group. The difference was statistically significant (P＜0.05). Conclusion Thoracoscopic surgery is better than traditional thoracotomy for early lung cancer patients.
万方数据